Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study will compare the effects, good and/or bad, of chemotherapy (Gemcitabine and
Cisplatin) with or without the addition of the chemotherapy drug Cetuximab to find out which
treatment is better.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center
Collaborators:
Bristol-Myers Squibb Eli Lilly and Company ImClone LLC National Comprehensive Cancer Network